Welcome to the University of Cape Town News
Wamkelekile, Welkom
Wamkelekile, Welkom
Stephanie Fanucchi recognised at the 19th L’Oréal-Unesco for Women in Science Awards
24 March 2017 | Department of Science and Technology
The 19th edition of the L’Oréal-UNESCO For Women in Science Awards International Rising Talent gala dinner took place this week in Paris. Dr Stephanie Fanucchi, a postdoctoral researcher the was one of 15 young female scientists recognised for her innovative research in cancer and auto-immune diseases.
The L’Oréal-UNESCO For Women in Science programme supports more than 260 young women scientists who are the “scientists of tomorrow” by accompanying them at a key moment in their careers, during their PhD thesis or post-doctoral studies. A L’Oréal-UNESCO For Women in Science fellowship is awarded to these researchers at national and regional ceremonies that take place in more than 45 different countries. Dr Fanucchi was one of two post-doctoral fellowship recipients for the 2016L’Oréal-UNESCO For Women in Science Sub-Saharan Africa Regional Programme.
Each year, among the national and regional fellows, the fifteen most promising young researchers are also honoured as “International Rising Talents”. These researchers were recognised at a dedicated International Rising Talents Gala dinner on March 21st, to celebrate their work.
Major advances in cell biology over the last 40 years have allowed scientists to learn a lot more about the immune system. Inflammation, the bodies protective response to injury or infection, is perceived as a double-edged sword, it is needed to clear infection but if it is not carefully regulated it leads to many diseases, like autoimmune disease, cancers and even sepsis. Sepsis is the uncontrolled activation of the immune system and is the leading cause of death in ICU’s worldwide. “Current approaches to treat inflammation are not always successful. This highlights the need to gain a detailed understanding of these processes, so we can develop new therapies and refine old ones,” says Fanucchi.
Gene regulation, or the mechanism whereby genes are switched on and off, is critical to how cells function, and regulates inflammation. “My work focuses on understanding how inflammation is controlled at the level of gene regulation. This is a highly complex process that is not fully understood. Critically, the ability to tune down this rapid response would be a very important therapy,” she further explains. Dr Stephanie Fanucchi works in the CSIR within the Biomedical Translational Research Initiative (BTRI) - an initiative of the Council for Scientific and Industrial Research (CSIR) and the University of Cape Town.
To study this process, Dr Fanucchi is using a combination of advanced microscopy and cell biology approaches in transgenic models. Her work came to the fore in 2013 thanks to a paper published in the prestigious journal Cell on the then poorly understood process of how 3D nuclear architecture influences gene regulation. Her current research will help refine targeted therapies for cancer and autoimmune diseases.
Talking about being named a L’Oréal-UNESCO For Women In Science International Rising Talent, Dr Fanucchi described the feeling as unreal. “Winning this award has been surreal and being exposed to such great scientific talent has been a life changing experience. Having the platform to discuss the importance of having more females in science has been a highlight for me. In addition, we get to celebrate phenomenal female scientific achievements which can inspire young girls who want to enter science.”
Since 1998, the L’Oréal Corporate Foundation and UNESCO have been committed to increase the number of women working in scientific research. 150 years after Marie Curie’s birth, only 28%* of researchers are women and only 3% of Scientific Nobel Prizes are awarded to them. Since the programme began, it has supported more than 2,700 young women from 115 countries and celebrated 97 Laureates, at the peak of their careers, including professors Elizabeth H. Blackburn and Ada Yonath, who went on to win a Nobel Prize.
The 2017 Edition of the L’Oréal-UNESCO For Women in Science Awards celebrates the excellence, the creativity and the intelligence of 5 eminent women scientists. The 5 Laureates will receive an Award of 100,000 € each on March 23rd at La Maison de la Mutualité in Paris to commend their scientific contributions in the fields of quantum physics, physical science and astrophysics.
The keynote speaker at the L’Oréal-UNESCO For Women in Science Awards ceremony will be the President of Mauritius, Ameenah Gurib Fakim who was elected in 2014 and is the country’s first female president. She was the 2007 L’Oréal-UNESCO For Women in Science Laureate for Africa and the Arab States. Her research focused on the exploration and analysis of plants from Mauritius and their bio-medical applications. Professor Gurib Fakim created the first-ever full inventory of the medicinal and aromatic plants on Mauritius and neighboring island Rodriguez. Her analysis of the antibacterial and antifungal properties of plants from Mauritius is paving the way for their use as safe and effective alternatives to commercial medicines.
This is a modified version of the original story produced by the Department of Science and Technology. Image courtesy Department of Science and Technology.
The international rising talents
The L’Oréal-UNESCO For Women in Science programme supports more than 260 young women scientists who are the “scientists of tomorrow” by accompanying them at a key moment in their careers, during their PhD thesis or post-doctoral studies. A L’Oréal-UNESCO For Women in Science fellowship is awarded to these researchers at national and regional ceremonies that take place in more than 45 different countries. Dr Fanucchi was one of two post-doctoral fellowship recipients for the 2016L’Oréal-UNESCO For Women in Science Sub-Saharan Africa Regional Programme.
Each year, among the national and regional fellows, the fifteen most promising young researchers are also honoured as “International Rising Talents”. These researchers were recognised at a dedicated International Rising Talents Gala dinner on March 21st, to celebrate their work.
Background of the research
Major advances in cell biology over the last 40 years have allowed scientists to learn a lot more about the immune system. Inflammation, the bodies protective response to injury or infection, is perceived as a double-edged sword, it is needed to clear infection but if it is not carefully regulated it leads to many diseases, like autoimmune disease, cancers and even sepsis. Sepsis is the uncontrolled activation of the immune system and is the leading cause of death in ICU’s worldwide. “Current approaches to treat inflammation are not always successful. This highlights the need to gain a detailed understanding of these processes, so we can develop new therapies and refine old ones,” says Fanucchi.
Gene regulation, or the mechanism whereby genes are switched on and off, is critical to how cells function, and regulates inflammation. “My work focuses on understanding how inflammation is controlled at the level of gene regulation. This is a highly complex process that is not fully understood. Critically, the ability to tune down this rapid response would be a very important therapy,” she further explains. Dr Stephanie Fanucchi works in the CSIR within the Biomedical Translational Research Initiative (BTRI) - an initiative of the Council for Scientific and Industrial Research (CSIR) and the University of Cape Town.
To study this process, Dr Fanucchi is using a combination of advanced microscopy and cell biology approaches in transgenic models. Her work came to the fore in 2013 thanks to a paper published in the prestigious journal Cell on the then poorly understood process of how 3D nuclear architecture influences gene regulation. Her current research will help refine targeted therapies for cancer and autoimmune diseases.
Talking about being named a L’Oréal-UNESCO For Women In Science International Rising Talent, Dr Fanucchi described the feeling as unreal. “Winning this award has been surreal and being exposed to such great scientific talent has been a life changing experience. Having the platform to discuss the importance of having more females in science has been a highlight for me. In addition, we get to celebrate phenomenal female scientific achievements which can inspire young girls who want to enter science.”
The 2017 L’Oréal-UNESCO for Women in Science Awards
Since 1998, the L’Oréal Corporate Foundation and UNESCO have been committed to increase the number of women working in scientific research. 150 years after Marie Curie’s birth, only 28%* of researchers are women and only 3% of Scientific Nobel Prizes are awarded to them. Since the programme began, it has supported more than 2,700 young women from 115 countries and celebrated 97 Laureates, at the peak of their careers, including professors Elizabeth H. Blackburn and Ada Yonath, who went on to win a Nobel Prize.
The 2017 Laureates women at the cutting edge
The 2017 Edition of the L’Oréal-UNESCO For Women in Science Awards celebrates the excellence, the creativity and the intelligence of 5 eminent women scientists. The 5 Laureates will receive an Award of 100,000 € each on March 23rd at La Maison de la Mutualité in Paris to commend their scientific contributions in the fields of quantum physics, physical science and astrophysics.
The keynote speaker at the L’Oréal-UNESCO For Women in Science Awards ceremony will be the President of Mauritius, Ameenah Gurib Fakim who was elected in 2014 and is the country’s first female president. She was the 2007 L’Oréal-UNESCO For Women in Science Laureate for Africa and the Arab States. Her research focused on the exploration and analysis of plants from Mauritius and their bio-medical applications. Professor Gurib Fakim created the first-ever full inventory of the medicinal and aromatic plants on Mauritius and neighboring island Rodriguez. Her analysis of the antibacterial and antifungal properties of plants from Mauritius is paving the way for their use as safe and effective alternatives to commercial medicines.
This is a modified version of the original story produced by the Department of Science and Technology. Image courtesy Department of Science and Technology.
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Please view the republishing articles page for more information.
